Thopaz+ portable digital system for managing chest drains (MTG37)
Evidence-based recommendations on Thopaz+ for managing chest drains
Evidence-based recommendations on Thopaz+ for managing chest drains
Evidence-based recommendations on Peristeen Plus transanal irrigation system for managing bowel dysfunction
Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms
Evidence-based recommendations on myCOPD for managing chronic obstructive pulmonary disease
Evidence-based recommendations on UroShield for preventing catheter-associated urinary tract infections
This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.
Evidence-based recommendations on Prontosan for treating acute and chronic wounds
Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care
Evidence-based recommendations on KardiaMobile for detecting atrial fibrillation
Evidence-based recommendations on Endo-SPONGE for treating low rectal anastomotic leak
Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections
Evidence-based recommendations on Synergo for non-muscle-invasive bladder cancer
Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography
This guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in adults, young people and children aged 72 hours and over in community and hospital settings. It aims to optimise antibiotic use and reduce antibiotic resistance. The recommendations do not cover diagnosis.
Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure